Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
JAMA Neurology|May 22, 2023
Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical TrialNadinda A M van der Ende, Bob Roozenbeek, Lucas E M Smagge, et al.Stroke|February 20, 2019
Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute StrokeÁngel Chamorro, Scott Brown, Sergio Amaro, et al.BMC Neurology|January 12, 2022
Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the NetherlandsFaysal Benali, Lotte J Stolze, Anouk D Rozeman, et al.The Lancet. Neurology|February 22, 2025
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort studyAnita van de Munckhof, Mayte Sánchez van Kammen, Turgut Tatlisumak, et al.Lancet (London, England)|March 3, 2022
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trialWouter van der Steen, Rob A van de Graaf, Vicky Chalos, et al.The New England Journal of Medicine|December 18, 2014
A randomized trial of intraarterial treatment for acute ischemic strokeOlvert A Berkhemer, Puck S S Fransen, Debbie Beumer, et al.JAMA Neurology|December 31, 2015
Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical TrialPuck S S Fransen, Olvert A Berkhemer, Hester F Lingsma, et al.The New England Journal of Medicine|November 10, 2021
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for StrokeNatalie E LeCouffe, Manon Kappelhof, Kilian M Treurniet, et al.Stroke|February 9, 2022
Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN RegistryKars C J Compagne, Manon Kappelhof, Wouter H Hinsenveld, et al.Lancet (London, England)|April 1, 2023
Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trialSusanne G H Olthuis, F Anne V Pirson, Florentina M E Pinckaers, et al.Pageof 12